Howard Trachtman, MD, Pediatric Nephrologist at NYU Langone Health provides an overview of focal segmental glomerulosclerosis (FSGS).

FSGS is a heterogeneous kidney disorder best defined as glomerular histopathology. Patients with FSGS typically present with a variable degree of proteinuria and often nephrotic syndrome. 

Currently, treatment often includes corticosteroids or other immunomodulating agents aimed to reduce proteinuria but new treatments, such as sparsentan are in development. Dr. Trachtman urges clinicians to refer their patients suspected of having FSGS to a specialty clinic so that the patient can receive proper care.

To learn more about this and other kidney disorders, visit kidney/